DA Davidson analyst Robert Simmons downgrades Monday.Com (NASDAQ:MNDY) from Buy to Neutral.
Why Is Retinal Diseases-Focused Opthea Stock Trading Higher Today?
Opthea Limited (NASDAQ: OPT) on Wednesday said it expects to receive the remaining $35 million committed funds under the Development Funding Agreement (DFA) with Carlyle and Abingworth, and has entered into binding documentation with a new co-investor under an Amended DFA to secure an additional
